您的位置： 百康网 > 期刊 > 药学 > 《药理学进展》 > 2005年12月第4期 > 正文
International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels
http://www.100kang.com 2007-6-8 10:53:25 Two-P


Department of Pediatrics and Institute for Molecular Pediatric Sciences. Pritzker School of Medicine, University of Chicago, Chicago, Illinois (S.A.N.G., L.D.P., S.R.); Department of Pharmacology, University of Virginia Health System, Charlottesville, Virginia (D.A.B.); Department of Physiology, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, Chicago, Illinois (D.K.); and Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France (F.L.)

Introduction

In less than a decade since their discovery, the study of K2P channels has revealed that background leak of potassium ions via dedicated pathways is a highly regulated mechanism to control cellular excitability. Potassium leak pathways, active at rest, stabilize membrane potential below firing threshold and expedite repolarization. Although the existence of leak currents was proposed in 1952 by Hodgkin and Huxley, they remained a biophysical curiosity for more than 4 decades. Identification of the first molecular correlate of a potassium leak current was preceded by cloning of potassium channels in Saccharomyces cerevisiae and Caenorhabditis elegans with two pore-forming P loops in each subunit and four or eight transmembrane (TM1) domains (Ketchum et al., 1995). Thereafter, K2P? was isolated by functional expression cloning from the neuromuscular tissue of Drosophilia melanogaster (Goldstein et al., 1996). Biophysical characterization revealed K2P? to be a potassium-selective channel with the predicted attributes of a background conductance, that is, a voltage-independent portal showing Goldman-Hodgkin-Katz (open) rectification. When the concentration of potassium is symmetrical across the membrane, K2P? currents change in a linear manner with voltage; under physiological conditions (high internal and low external potassium), K2P? passes greater outward than inward currents (Goldstein et al., 2001).

A striking feature of K2P channels is their subunit body plan: each has two P loops and four TM domains. This distinct 2P/4TM topology can be found in more than 70 predicted homologs in genome databases. Fifteen mammalian genes in the family are designated as KCNK genes encoding the K2P channels (Fig. 1); most readily reveal ion channel function upon expression. As expected for regulators of excitability, K2P channels are under tight control by a plethora of chemical and physical stimuli, including oxygen tension, pH, lipids, mechanical stretch, neurotransmitters, and G protein-coupled receptors; the channels are also the molecular targets for certain volatile and local anesthetics (Lesage and Lazdunski, 2000). Regulation of K2P channels alters the attributes subject to change in any ion channel: number of pores at the site of operation, open probability, and unitary current (Plant et al., 2005). Nonetheless, some regulatory changes are striking; for example, phosphorylation of K2P2 endows the open rectifier with sensitivity to voltage (Bockenhauer et al., 2001), and desumoylation of K2P1 (removal of covalently-bound small ubiquitin-modifier protein) relieves chronic silencing of complexes that reside in the plasma membrane, thereby revealing that the protein can function as an ion channel and operates like K2P? as an open rectifier (Plant et al., 2005; Rajan et al., 2005). Tables 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 present the properties of K2P1.1 through K2P18.1 channels.

FIG. 1. Phylogenetic tree for K2P channels. Amino acid sequence alignments and phylogenetic analysis for the 15 known members of the human K2P family were generated as described in the legend for Fig. 1 of "LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels." K2P18.1 was added to the topology shown in the previous edition of this compendium by use of maximum parsimony and neighbor-joining algorithms. International Union of Pharmacology and HUGO Gene Nomenclature Committee names of the genes are shown together with their chromosomal localization.

TABLE 1 K2P1.1 channels

TABLE 2 K2P2.1 channels

TABLE 3 K2P3.1 channels

TABLE 4 K2P4.1 channels

TABLE 5 K2P5.1 channels

TABLE 6 K2P6.1 channels

TABLE 7 K2P7.1 channels

TABLE 8 K2P9.1 channels

TABLE 9 K2P10.1 channels

TABLE 10 K2P12.1 channels

TABLE 11 K2P13.1 channels

TABLE 12 K2P15.1 channels

TABLE 13 K2P16.1 channels

TABLE 14 K2P17.1 channels

TABLE 15 K2P18.1 channels

Address correspondence to: Dr. Steve A. N. Goldstein, Department of Pediatrics and Institute for Molecular Pediatric Sciences, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637. E-mail: sangoldstein@uchicago.edu

References

Bockenhauer D, Zilberberg N, and Goldstein SA (2001) KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci 4: 486-491.

Goldstein SA, Bockenhauer D, O'Kelly I, and Zilberberg N (2001) Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2: 75-84.

Goldstein SAN, Price LA, Rosenthal DN, and Pausch MH (1996) ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 93: 13256-13261.

Ketchum KA, Joiner WJ, Sellers AJ, Kaczmarek LK, and Goldstein SAN (1995) A new family of outwardly-rectifying potassium channel proteins with two pore domains in tandem. Nature (Lond) 376: 690-695.

Lesage F and Lazdunski M (2000) Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol. 279: F793-F801.

Plant LD, Rajan S, and Goldstein SA (2005) K2P channels and their protein partners. Curr Opin Neurobiol 15: 326-333.

Rajan S, Plant LD, Rabin ML, Butler MH, and Goldstein SAN (2005) Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell 121: 37-47.

All authors serve as the Subcommittee on K2P Channels of the Nomenclature Committee of the International Union of Pharmacology.


  
《药理学进展》医学期刊2005年12月第57卷第4期